Skip to content
Review Open access

Cognitive Stimulation and Training in People with Mild-to-Moderate Alzheimer’s Disease: A Scoping Review

Sep 2026 · Brain Science · Vol 16, pp. 944 · 0 citations · 20 references
Medicine

TL;DR

The mapped evidence suggests that structured cognitive stimulation and training may produce short-term, outcome-specific benefits in mild-to-moderate Alzheimer’s disease.

Abstract

Highlights What are the main findings? The included studies showed short-term, outcome-specific patterns across structured cognitive stimulation and training interventions. Technology-assisted and conventional cognitive training primarily showed signals in cognitive outcomes, whereas reminiscence-based interventions more consistently reported changes in depressive and neuropsychiatric symptoms. What are the implications of the main findings? Cognitive stimulation and training may complement comprehensive, person-centred care, but current evidence is insufficient to establish comparative effectiveness or long-term benefits. Larger studies with standardized outcomes, replicable interventions, and longer follow-up are needed, including evaluation of maintenance or booster strategies. Abstract Background/Objectives: Cognitive stimulation and cognitive training are used as non-pharmacological approaches to support people living with Alzheimer’s disease, but Alzheimer-specific evidence is dispersed across heterogeneous intervention formats. This scoping review mapped structured cognitive stimulation and training interventions evaluated in people with mild-to-moderate Alzheimer’s disease and summarized the cognitive, emotional, functional, and follow-up outcomes reported. Methods: The review was conducted using the Joanna Briggs Institute methodology and reported according to PRISMA-ScR. PubMed, SciELO, PEDro, LILACS, and Google Scholar were searched on 24 February 2025 for studies published between January 2015 and 24 February 2025 in English, Portuguese, or Spanish. Intervention studies were eligible. Two reviewers independently screened records and charted data, with disagreements resolved by a third reviewer. Results: Of 352 records identified, five studies involving 245 participants were included. Interventions comprised virtual-reality cognitive stimulation, conventional cognitive training, group reminiscence therapy, a multicomponent music–reminiscence–reality-orientation intervention, and computerized cognitive training. In the limited technology-assisted evidence, statistically significant changes were reported in global cognition or selected memory, language, attention, and executive outcomes. Conventional cognitive training showed signals of improvement in initiative and temporary stabilization of memory, whereas reminiscence-based interventions primarily reported changes in depressive and neuropsychiatric symptoms. Where longer follow-up was available, benefits diminished over time. Conclusions: The mapped evidence suggests that structured cognitive stimulation and training may produce short-term, outcome-specific benefits in mild-to-moderate Alzheimer’s disease. Given the small and heterogeneous evidence base, these findings represent modality-related patterns within the included studies and should not be interpreted as evidence of comparative effectiveness.

Read PDF

Similar papers

Oct 2026

Home-delivered transcranial direct current stimulation with or without cognitive training in mild dementia due to Alzheimer's disease.

BackgroundTranscranial direct current stimulation (tDCS) and cognitive training are non-pharmacological interventions for cognitive impairment in Alzheimer's disease (AD), but evidence on combined protocols in mild dementia remains limited.ObjectiveTo evaluate home-delivered active tDCS combined with cognitive training...

J. Mélendez, J. Escudero, E. Satorres et al. · 0 citations
Review Open access Sep 2026

Deep brain stimulation in Alzheimer’s disease: a systematic review and meta-analysis of cognitive outcomes

Deep brain stimulation (DBS) has emerged as a potential neuromodulatory approach for Alzheimer’s disease (AD) by targeting neural circuits involved in memory and cognition. However, clinical evidence remains limited, with small studies reporting inconsistent findings across different stimulation targets and cogni...

Amir Mahdi Taghizadeh · 0 citations
Review Open access 2026

Role of non-pharmacological cognition building techniques in delayed progression of Alzheimer's disease: A matter of blood-brain barrier dysfunction

Cognitive rehabilitation treatments for Alzheimer's disease and early-stage dementia are increasingly accessible to older adults and aim to slow the progressive decline in functional performance and cognitive abilities associated with ageing. Alzheimer's disease may involve disruption of affected brain systems, impaire...

S. Dhankhar, R. Gautam, Samrat Chauhan et al. · 0 citations
Review Open access Sep 2026

Non-pharmacological interventions for cognitive function improvement in patients with Alzheimer's disease: a best evidence summary

Objective This study aimed to systematically retrieve, analyze, and synthesize evidence on non-pharmacological interventions to improve overall cognitive function in patients with Alzheimer's disease (AD), providing evidence-based references for selecting and optimizing these interventions. Methods This review followed...

Na-Na Wang, L. Dang, Wei Chang et al. · 0 citations
Open access Sep 2026

186. Effects of a nature-based intervention on cognitive function in older adults with mild cognitive impairment

Abstract Background Mild Cognitive Impairment (MCI) represents a high-risk stage for dementia. Pharmacological treatments for MCI have demonstrated limited efficacy and are frequently associated with adverse effects. Despite recent approvals of Donanemab and Lecanemab, their high cost, complex use, and serious side eff...

D. Kim, Eunkyung Kwan, Y. S. Moon · 0 citations
Review Sep 2026

Mobile application-based interventions for subjective memory decline and mild cognitive impairment: A systematic review.

BackgroundSubjective cognitive decline (SCD) and mild cognitive impairment (MCI) are early clinical markers along the continuum from normal aging to dementia. Both conditions are associated with an elevated risk of progression to Alzheimer's disease and related dementias. With SCD affecting up to 25% and MCI up to 25.2...

Cynthia Zou, Ana-Sophia Chung, Milly Tadigiri et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.